-
Mashup Score: 0Avacincaptad pegol shows promise for AMD-related geographic atrophy - 7 month(s) ago
With few adverse side effects reported and significant reductions in geographic atrophy seen, avacincaptad pegol may help minimize central vision loss due to age-related macular degeneration (AMD).
Source: www.aao.orgCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0YouTube - 7 month(s) ago
La degeneración macular relacionada con la edad (DMRE) es una de las principales causas de pérdida irreversible de la visión entre los estadounidenses mayores de 60 años. Un estilo de vida saludable puede ayudar a disminuir el riesgo de desarrollar DMRE o ayuda a proteger la visión restante si ya tiene DMRE. En cualquier caso, una vida saludable contribuye al bienestar general. No fumar. Los Centros para el Control y la Prevención de Enfermedades de los Estados Unidos (CDC por sus siglas en inglés) dicen
Source: www.brightfocus.orgCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 1Retinal Physician - September 2023 AMD Issue - 8 month(s) ago
Speakers: Drs. Jay Sridhar, Katherine Talcott, Joshua Uhr, and Akshay Thomas Listen now
Source: www.retinalphysician.comCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0Expanding Retina’s Armamentarium - 9 month(s) ago
By Christine Yue Leonard, Senior Associate Editor W ithin the space of just a few years, several new retinal treatments have been ap proved for wet age-related macular degeneration, diabetic macular edema and retinal vein occlusion, promising increased durability and better drying. These toolbox additions are encouraging for treating resistant and newly diagnosed patients. As with any newly available treatment, uptake is often gradual, and doctors may wonder whether it’s worth it to stock another drug.
Source: www.reviewofophthalmology.comCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0Current Treatment Options for nAMD - 10 month(s) ago
Experts offer clinical advice on identifying and managing suboptimal responders on anti-vascular endothelial growth factor (Anti-VEGF) treatment.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0iHealthScreen receives FDA 510(k) for AI-enabled eye screening system - 11 month(s) ago
The company’s iPredict System allows providers to detect age-related macular degeneration in the clinical setting.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Minocycline Doesn't Slow Geographic Atrophy in AMD - 1 year(s) ago
A potential drug for age-related macular degeneration failed to slow geographic atrophy, according to data from a long-term study.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Extremely rare gene variants and AMD - 1 year(s) ago
A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular …
Source: YouTubeCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0Treating Difficult Cases of Wet AMD - 1 year(s) ago
Retina specialists have been treating neovascular age-related macular degeneration with anti-vascular endothelial growth factor therapies for years. Though it’s been remarkably successful for many patients, there are still those few who don’t respond to their initial anti-VEGF treatment and need something more. Here, retina specialists discuss how they handle recalcitrant wet AMD.Starting…
Source: www.reviewofophthalmology.comCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0
The Ryan Initiative for Macular Research (originally the Beckman Initiative) brings together a broad range of scientists and clinicians focused on developing a research agenda for understanding and treating age-related macular degeneration (AMD). In yearly meetings, facilitated discussion groups are tasked with generating a report on optimal research programs related to AMD, in specific focus…
Source: www.sciencedirect.comCategories: Latest Headlines, NeurologyTweet-
Read this new special issue published in Experimental Eye Research: Strategies for the future of Age-Related #MacularDegeneration research-reports from the Ryan Initiative for Macular Research. Edited by @DrMarieCsete & Frederick Ferris. Read the issue https://t.co/7gJnRdgtMF https://t.co/QDvmRntNbY
-
Promising results continue to be seen after an 18-month trial of avacincaptad pegol for #geographicatrophy due to age-related #maculardegeneration https://t.co/mPlOt6CvdQ #retina